Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Updated: May 5, 2026
Alec Stranahan's Stock Ratings
B of A Securities Analyst
Alec Stranahan is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
-40.1%
Smart Score
Overall Average Return Percentile
4th
Number of Ratings
42
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/27/2026 | WVE | Buy Now | WAVE Life Sciences | $7.49 | 180.37% | $38 → $21 | Maintains | Buy | Get Alert | |
| 01/22/2026 | KRYS | Buy Now | Krystal Biotech | $296.19 | 7.36% | $288 → $318 | Maintains | Buy | Get Alert | |
| 10/17/2025 | KRYS | Buy Now | Krystal Biotech | $296.19 | -13.91% | $182 → $255 | Maintains | Buy | Get Alert | |
| 09/03/2025 | CADL | Buy Now | Candel Therapeutics | $7.75 | -9.74% | $13 → $7 | Downgrade | Buy → Neutral | Get Alert | |
| 09/03/2025 | XNCR | Buy Now | Xencor | $13.52 | -11.24% | $23 → $12 | Downgrade | Buy → Neutral | Get Alert | |
| 09/03/2025 | ERAS | Buy Now | Erasca | $10.30 | -90.29% | $4 → $1 | Downgrade | Buy → Underperform | Get Alert | |
| 08/20/2025 | NVAX | Buy Now | Novavax | $8.10 | -13.58% | $9 → $7 | Downgrade | Neutral → Underperform | Get Alert | |
| 07/22/2025 | NVAX | Buy Now | Novavax | $8.10 | 11.11% | $10 → $9 | Maintains | Neutral | Get Alert | |
| 07/22/2025 | KRYS | Buy Now | Krystal Biotech | $296.19 | -35.18% | $193 → $192 | Maintains | Buy | Get Alert | |
| 03/28/2025 | BEAM | Buy Now | Beam Therapeutics | $30.80 | 36.36% | $42 → $42 | Upgrade | Neutral → Buy | Get Alert | |
| 03/05/2025 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $14 → $12 | Maintains | Neutral | Get Alert | |
| 02/07/2025 | CADL | Buy Now | Candel Therapeutics | $7.75 | 93.42% | → $15 | Initiates | → Buy | Get Alert | |
| 01/07/2025 | DAWN | Buy Now | Day One Biopharmaceutical | — | — | $28 → $25 | Maintains | Buy | Get Alert | |
| 01/07/2025 | CRBU | Buy Now | Caribou Biosciences | $1.95 | 464.1% | $13 → $11 | Maintains | Buy | Get Alert | |
| 01/07/2025 | ERAS | Buy Now | Erasca | $10.30 | -51.46% | $5 → $5 | Upgrade | Neutral → Buy | Get Alert | |
| 11/25/2024 | CATX | Buy Now | Perspective Therapeutics | $3.87 | 55.24% | $24 → $6 | Downgrade | Buy → Neutral | Get Alert | |
| 10/31/2024 | DAWN | Buy Now | Day One Biopharmaceutical | — | — | $24 → $28 | Maintains | Buy | Get Alert | |
| 08/08/2024 | EDIT | Buy Now | Editas Medicine | $3.07 | 388.6% | $13 → $15 | Upgrade | Neutral → Buy | Get Alert | |
| 08/01/2024 | DAWN | Buy Now | Day One Biopharmaceutical | — | — | $11 → $24 | Upgrade | Underperform → Buy | Get Alert | |
| 07/25/2024 | CATX | Buy Now | Perspective Therapeutics | $3.87 | 520.96% | → $24 | Initiates | → Buy | Get Alert | |
| 07/16/2024 | RVMD | Buy Now | Revolution Medicines | $147.53 | -62.72% | $48 → $55 | Maintains | Buy | Get Alert | |
| 06/14/2024 | NVAX | Buy Now | Novavax | $8.10 | 122.22% | $12 → $18 | Maintains | Neutral | Get Alert | |
| 05/10/2024 | NVAX | Buy Now | Novavax | $8.10 | 48.15% | $4 → $12 | Upgrade | Underperform → Neutral | Get Alert | |
| 01/05/2024 | ERAS | Buy Now | Erasca | $10.30 | -41.75% | $11 → $6 | Downgrade | Buy → Neutral | Get Alert | |
| 01/05/2024 | RVMD | Buy Now | Revolution Medicines | $147.53 | -76.95% | → $34 | Upgrade | Neutral → Buy | Get Alert | |
| 05/25/2023 | KRYS | Buy Now | Krystal Biotech | $296.19 | -52.73% | $118 → $140 | Maintains | Buy | Get Alert | |
| 05/22/2023 | KRYS | Buy Now | Krystal Biotech | $296.19 | -60.16% | $105 → $118 | Maintains | Buy | Get Alert | |
| 05/19/2023 | XNCR | Buy Now | Xencor | $13.52 | 210.65% | → $42 | Initiates | → Buy | Get Alert | |
| 05/15/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $6 → $12 | Maintains | Neutral | Get Alert | |
| 04/25/2023 | DAWN | Buy Now | Day One Biopharmaceutical | — | — | $34 → $9 | Downgrade | Buy → Underperform | Get Alert | |
| 04/01/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | → $6 | Maintains | Neutral | Get Alert | |
| 12/29/2022 | TGTX | Buy Now | TG Therapeutics | $35.90 | -83.29% | $5 → $6 | Maintains | Underperform | Get Alert | |
| 12/15/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $5 → $6 | Maintains | Neutral | Get Alert | |
| 12/02/2022 | HOOK | Buy Now | HOOKIPA Pharma | $1.18 | -57.63% | $6 → $0.5 | Downgrade | Buy → Underperform | Get Alert | |
| 12/02/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $23 → $5 | Downgrade | Buy → Neutral | Get Alert | |
| 12/01/2022 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | → $45 | Initiates | → Buy | Get Alert | |
| 12/01/2022 | DAWN | Buy Now | Day One Biopharmaceutical | — | — | → $34 | Initiates | → Buy | Get Alert | |
| 05/20/2022 | NVAX | Buy Now | Novavax | $8.10 | — | — | Initiates | → Underperform | Get Alert | |
| 05/20/2022 | TGTX | Buy Now | TG Therapeutics | $35.90 | -86.07% | → $5 | Initiates | → Underperform | Get Alert | |
| 05/20/2022 | RVMD | Buy Now | Revolution Medicines | $147.53 | -83.73% | → $24 | Initiates | → Neutral | Get Alert | |
| 05/20/2022 | TPTX | Buy Now | Turning Point | — | — | → $58 | Initiates | → Buy | Get Alert | |
| 01/18/2022 | KRYS | Buy Now | Krystal Biotech | $296.19 | -62.86% | → $110 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved